Become of Patients Infected or Suspected of Being Infected by Covid-19 and Supported by the GHPSJ and the Establishments of the Paris Plaisance Hospital City
COVIDGHPSJCite
1 other identifier
observational
3,767
1 country
5
Brief Summary
The ongoing Coronavirus (Covid-19) pandemic is causing a major global health crisis and is shaking up hospital organizations. To date, the recognized risk factors for severe forms of Covid-19 infection are elderly patients (\> 70 years), obese patients, patients with chronic renal or respiratory pathologies, cardiovascular history (stroke or coronary artery disease), chronic respiratory conditions, high blood pressure, diabetes, and cancer. Covid-19 is manifested by a risk of acute respiratory distress syndrome requiring management by invasive ventilation. The lethality of this infection is around 4% in the current data. Drastic precautionary measures for the transmission of the virus, as well as the provision of critical care beds by canceling any scheduled non-urgent intervention or consultation, have shaken up the hospital organization. In this context, it is essential to have forward-looking data in real time to adjust the care offer and better understand the impact of Covid-19 on the patient populations treated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2020
Typical duration for all trials
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2020
CompletedFirst Submitted
Initial submission to the registry
April 26, 2020
CompletedFirst Posted
Study publicly available on registry
April 28, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 6, 2023
CompletedMarch 7, 2023
March 1, 2023
2.2 years
April 26, 2020
March 6, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Clinical consequences of a Covid-19 infection in the care population
This outcome measures the clinical consequences of a Covid-19 infection in the care population.
Year 2
Secondary Outcomes (6)
Risk factors at M6
Month 6
Risk factors at year 1
Year 1
Risk factors at year 2
Year 2
Impact of hospital reorganization on medical care at M6
Month 6
Impact of hospital reorganization on medical care at Year 1
Year 1
- +1 more secondary outcomes
Eligibility Criteria
Patientwith symptoms compatible with infection by Covid-19 treated at the GHPSJ or in one of the establishments in the Paris Plaisance hospital city.
You may qualify if:
- \- Patient (of all ages) with symptoms compatible with infection by Covid-19 treated at the GHPSJ or in one of the establishments in the Paris Plaisance hospital city.
You may not qualify if:
- Asymptomatic patient
- Patient objecting to the use of their data
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
Hôpital Marie Lannelongue
Le Plessis-Robinson, 92350, France
AURA Paris Plaisance
Paris, 75014, France
Fondation Sainte-Marie
Paris, 75014, France
Groupe Hospitalier Paris Saint-Joseph
Paris, 75014, France
Hôpital Bellan
Paris, 75014, France
Study Officials
- PRINCIPAL INVESTIGATOR
Benoit PILMIS, MD
Fondation Hôpital Saint-Joseph
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 26, 2020
First Posted
April 28, 2020
Study Start
April 1, 2020
Primary Completion
June 30, 2022
Study Completion
March 6, 2023
Last Updated
March 7, 2023
Record last verified: 2023-03